Rapid Micro Biosystems (NASDAQ:RPID) COO Sells $21,179.76 in Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) COO John Addington Wilson sold 5,403 shares of Rapid Micro Biosystems stock in a transaction on Friday, February 20th. The shares were sold at an average price of $3.92, for a total value of $21,179.76. Following the completion of the transaction, the chief operating officer owned 326,365 shares in the company, valued at $1,279,350.80. This represents a 1.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Rapid Micro Biosystems Trading Down 2.0%

Shares of NASDAQ RPID opened at $3.89 on Monday. Rapid Micro Biosystems, Inc. has a 1-year low of $1.86 and a 1-year high of $4.94. The business has a fifty day moving average price of $3.67 and a 200 day moving average price of $3.41. The stock has a market capitalization of $172.40 million, a P/E ratio of -3.85 and a beta of 1.38. The company has a debt-to-equity ratio of 0.42, a current ratio of 4.23 and a quick ratio of 2.95.

Institutional Trading of Rapid Micro Biosystems

Institutional investors have recently bought and sold shares of the stock. Hudson Bay Capital Management LP purchased a new stake in Rapid Micro Biosystems during the 3rd quarter worth approximately $38,000. American Century Companies Inc. grew its holdings in shares of Rapid Micro Biosystems by 46.1% during the second quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock valued at $58,000 after buying an additional 5,341 shares during the last quarter. Fifth Lane Capital LP purchased a new stake in shares of Rapid Micro Biosystems during the fourth quarter valued at $51,000. OMERS ADMINISTRATION Corp acquired a new position in shares of Rapid Micro Biosystems in the 4th quarter valued at $71,000. Finally, Barclays PLC purchased a new position in Rapid Micro Biosystems in the 4th quarter worth $72,000. 52.60% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on RPID. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Thursday, January 22nd. Wall Street Zen raised shares of Rapid Micro Biosystems from a “sell” rating to a “hold” rating in a report on Saturday, February 14th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $8.00.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.